Literature DB >> 7152202

Assessment of anti-tumor cell effect of human leukocyte interferon in combination with anticancer agents by a convenient assay system in monolayer cell culture.

T Oku, J Imanishi, T Kishida.   

Abstract

Cell growth inhibition by anticancer agents was determined by a simple dye-uptake method. This technique could be performed more easily and rapidly than the cell counting method, the method for measurement of 3H-thymidine incorporation, or other dye-uptake methods. The number of viable cells was linearly correlated with the amount of dye taken by the surviving cells, so that the method described in this article could be applied to the assessment of anti-tumor cell effects of human leukocyte interferon (Hu IFN-alpha) in combination with anticancer agents. In combinations of Hu IFN-alpha with anticancer agents such as bleomycin, mitomycin C, and cytosine arabinoside in certain concentration ranges, antagonism was noticed when Hu IFN-alpha and anticancer agents were added simultaneously to the cell culture. However, outside those ranges of concentration, additive effects were observed. Furthermore, the treatment of the cell with IFN followed by the anticancer agents and vice versa showed additive effects.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7152202

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  3 in total

1.  In vitro chemosensitivity tests on human tumor xenografts by clonogenic assay: the combined use of mitomycin C with alpha-interferon or gamma-interferon.

Authors:  N Hirabayashi; K Yoshinaka; Y Nosoh; T Toge; M Niimoto; T Hattori; T Ohkita
Journal:  Jpn J Surg       Date:  1985-07

2.  Positive interactions between human interferon and cepharanthin against human cancer cells in vitro and in vivo.

Authors:  M Ono; N Tanaka; K Orita
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Hyperthermic enhancement of the antitumor effect of natural human tumor necrosis factor-alpha and -beta: an in vitro and in vivo study.

Authors:  T Maeda; S Fuchimoto; K Orita
Journal:  Jpn J Cancer Res       Date:  1988-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.